Literature DB >> 15278564

Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane.

Y Sakaguchi1, S Inaba, Y Umeki, S Takahashi, J Yoshitake, Y Hayashi, K Akazawa, Y Nose.   

Abstract

The incidence of post-anesthetic mild liver disorder (PAMLD) was compared between 928 patients administered halothane and 1766 patients administered enflurane. They were selected from 19 504 surgical patients administered general anesthesia at Kyushu University Hospital over the past 6 years and 4 months. They had had normal liver function before operation and had no history of blood transfusion. Alanine aminotransferase (ALT) levels exceeding 70 IU. l(-1) within 180 days after operation were found in 226 patients in the halothane group (24.4%), and in 250 patients in the enflurane group (14.2%) ( P < 0.01). Both maximum ALT levels and duration of ALT elevation were higher and longer in the halothane group ( P < 0.01). These results suggest that, not only in the development of fulminant hepatitis but also in PAMLD, enflurane is less hepatotoxic than halothane.

Entities:  

Year:  1992        PMID: 15278564     DOI: 10.1007/s0054020060183

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  34 in total

1.  Liver function tests following anaesthesia.

Authors:  J McEwan
Journal:  Br J Anaesth       Date:  1976-11       Impact factor: 9.166

2.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Halothane hepatotoxicity--again?

Authors:  S Gelman
Journal:  Anesth Analg       Date:  1986-08       Impact factor: 5.108

4.  Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis.

Authors:  D D Christ; J G Kenna; W Kammerer; H Satoh; L R Pohl
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

5.  Hepatic blood flow in humans during isoflurane-N2O and halothane-N2O anesthesia.

Authors:  G Goldfarb; B Debaene; E T Ang; D Roulot; P Jolis; D Lebrec
Journal:  Anesth Analg       Date:  1990-10       Impact factor: 5.108

6.  Hepatic circulation during surgical stress and anesthesia with halothane, isoflurane, or fentanyl.

Authors:  S Gelman; E Dillard; E L Bradley
Journal:  Anesth Analg       Date:  1987-10       Impact factor: 5.108

7.  Enflurane hepatotoxicity. A clinicopathologic study of 24 cases.

Authors:  J H Lewis; H J Zimmerman; K G Ishak; F G Mullick
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

8.  Controlled prospective study of the effect on liver function of multiple exposures to halothane.

Authors:  R Wright; O E Eade; M Chisholm; M Hawksley; B Lloyd; T M Moles; J C Edwards; M J GArdner
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

9.  Effects of enflurane and halothane on liver blood flow and oxygen consumption in the greyhound.

Authors:  R L Hughes; D Campbell; W Fitch
Journal:  Br J Anaesth       Date:  1980-11       Impact factor: 9.166

10.  Hypoxia may be more important than reductive metabolism in halothane-induced hepatic injury.

Authors:  K Shingu; E I Eger; B H Johnson
Journal:  Anesth Analg       Date:  1982-10       Impact factor: 5.108

View more
  1 in total

1.  Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.

Authors:  Y Sakaguchi; S Inaba; K Irita; H Sakai; H Nawata; S Takahashi
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.